271 related articles for article (PubMed ID: 34709970)
1. Expression, prognosis value, and immune infiltration of lncRNA ASB16-AS1 identified by pan-cancer analysis.
Wu L; Liao W; Wang X; Zhao Y; Pang J; Chen Y; Yang H; He Y
Bioengineered; 2021 Dec; 12(2):10302-10318. PubMed ID: 34709970
[TBL] [Abstract][Full Text] [Related]
2. ASB16-AS1 up-regulated and phosphorylated TRIM37 to activate NF-κB pathway and promote proliferation, stemness, and cisplatin resistance of gastric cancer.
Fu T; Ji K; Jin L; Zhang J; Wu X; Ji X; Fan B; Jia Z; Wang A; Liu J; Bu Z; Ji J
Gastric Cancer; 2021 Jan; 24(1):45-59. PubMed ID: 32572790
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA ASB16-AS1 enhances cell proliferation, migration and invasion via functioning as a ceRNA through miR-1305/Wnt/β-catenin axis in cervical cancer.
Liu W; Zhuang R; Feng S; Bai X; Jia Z; Kapora E; Tan W
Biomed Pharmacother; 2020 May; 125():109965. PubMed ID: 32058219
[TBL] [Abstract][Full Text] [Related]
4. LncRNA WAC-AS1 expression in human tumors correlates with immune infiltration and affects prognosis.
Wang Y; Gong H; Cao Y
Hereditas; 2023 May; 160(1):26. PubMed ID: 37248547
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA F11-AS1 inhibits HBV-related hepatocellular carcinoma progression by regulating NR1I3 via binding to microRNA-211-5p.
Deng Y; Wei Z; Huang M; Xu G; Wei W; Peng B; Nong S; Qin H
J Cell Mol Med; 2020 Jan; 24(2):1848-1865. PubMed ID: 31880390
[TBL] [Abstract][Full Text] [Related]
6. LncRNA ASB16-AS1 promotes proliferation and inhibits apoptosis of non small cell lung cancer cells by activating the Wnt/β catenin signaling pathway.
Tan LJ; Liu JT; Yang M; Ju T; Zhang YS
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1870-1876. PubMed ID: 32141556
[TBL] [Abstract][Full Text] [Related]
7. LncRNA ASB16-AS1 accelerates cellular process and chemoresistance of ovarian cancer cells by regulating GOLM1 expression via targeting miR-3918.
Fan Y; Wang L; Han X; Ma H; Zhang N; She L
Biochem Biophys Res Commun; 2023 Oct; 675():1-9. PubMed ID: 37429067
[TBL] [Abstract][Full Text] [Related]
8. [LncRNA ASB16-AS1 regulates the proliferation, migration and invasion of esophageal cancer cells by targeting miR-1258].
Jia Z; Wang PS; Yang Y; Zhu DY; Wang ZH; Wang W
Zhonghua Zhong Liu Za Zhi; 2021 Jul; 43(7):762-768. PubMed ID: 34289570
[No Abstract] [Full Text] [Related]
9. LncRNA ASB16-AS1 drives proliferation, migration, and invasion of colorectal cancer cells through regulating miR-185-5p/TEAD1 axis.
Yu M; Shi C; Xu D; Lin X; Ji T; Shi Z; Zhuge X; Zhuo S; Yang Q
Cell Cycle; 2022 Jan; 21(1):1-11. PubMed ID: 34870557
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA SBF2-AS1 promotes hepatocellular carcinoma progression through regulation of miR-140-5p-TGFBR1 pathway.
Li Y; Liu G; Li X; Dong H; Xiao W; Lu S
Biochem Biophys Res Commun; 2018 Sep; 503(4):2826-2832. PubMed ID: 30115383
[TBL] [Abstract][Full Text] [Related]
11. The clinical significance and biological function of lncRNA RGMB-AS1 in hepatocellular carcinoma.
Sheng N; Li Y; Qian R; Li Y
Biomed Pharmacother; 2018 Feb; 98():577-584. PubMed ID: 29288973
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2.
Zhang DY; Sun QC; Zou XJ; Song Y; Li WW; Guo ZQ; Liu SS; Liu L; Wu DH
J Exp Clin Cancer Res; 2020 Oct; 39(1):229. PubMed ID: 33121524
[TBL] [Abstract][Full Text] [Related]
13. The long non-coding RNA TP73-AS1 modulates HCC cell proliferation through miR-200a-dependent HMGB1/RAGE regulation.
Li S; Huang Y; Huang Y; Fu Y; Tang D; Kang R; Zhou R; Fan XG
J Exp Clin Cancer Res; 2017 Apr; 36(1):51. PubMed ID: 28403886
[TBL] [Abstract][Full Text] [Related]
14. Long Noncoding RNA (lncRNA) FOXD2-AS1 Promotes Cell Proliferation and Metastasis in Hepatocellular Carcinoma by Regulating MiR-185/AKT Axis.
Chen Z; Zhang Z; Zhao D; Feng W; Meng F; Han S; Lin B; Shi X
Med Sci Monit; 2019 Dec; 25():9618-9629. PubMed ID: 31841454
[TBL] [Abstract][Full Text] [Related]
15. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
[TBL] [Abstract][Full Text] [Related]
16. Long Noncoding RNA ASB16-AS1 Promotes Proliferation, Migration, and Invasion in Glioma Cells.
Zhang D; Zhou H; Liu J; Mao J
Biomed Res Int; 2019; 2019():5437531. PubMed ID: 30949502
[TBL] [Abstract][Full Text] [Related]
17. Overexpressed lncRNA CDKN2B-AS1 is an independent prognostic factor for liver cancer and promotes its proliferation.
Zhuang H; Cao G; Kou C; Li D
J BUON; 2019; 24(4):1441-1448. PubMed ID: 31646789
[TBL] [Abstract][Full Text] [Related]
18. LncRNA F11-AS1 suppresses liver hepatocellular carcinoma progression by competitively binding with miR-3146 to regulate PTEN expression.
Du J; Chen M; Liu J; Hu P; Guan H; Jiao X
J Cell Biochem; 2019 Oct; 120(10):18457-18464. PubMed ID: 31168823
[TBL] [Abstract][Full Text] [Related]
19. LncRNA SOX21-AS1 is associated with progression of hepatocellular carcinoma and predicts prognosis through epigenetically silencing p21.
Wei C; Wang H; Xu F; Liu Z; Jiang R
Biomed Pharmacother; 2018 Aug; 104():137-144. PubMed ID: 29772433
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma.
He H; Wang Y; Ye P; Yi D; Cheng Y; Tang H; Zhu Z; Wang X; Jin S
J Exp Clin Cancer Res; 2020 Aug; 39(1):159. PubMed ID: 32795316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
